Use of Oral Budesonide in the Management of Protein-Losing Enteropathy After the Fontan Operation [ORIGINAL ARTICLES: PEDIATRIC CARDIAC]

Conclusions Oral budesonide is an effective therapy for treating protein-losing enteropathy after the Fontan operation. To maintain response, low-dose therapy must be continued

Follow this link:
Use of Oral Budesonide in the Management of Protein-Losing Enteropathy After the Fontan Operation [ORIGINAL ARTICLES: PEDIATRIC CARDIAC]

Related posts:

1. Use of Oral Budesonide in the Management of Protein-Losing Enteropathy After the Fontan Operation. CONCLUSIONS: Oral budesonide is an effective therapy for treating protein-losing...
2. [Original articles] Treatment of acne with oral isotretinoin in patients with cystic fibrosis Conclusions: Adolescents with cystic fibrosis and acne can be treated...
3. Implications of ER Stress, the Unfolded Protein Response, and Pro- and Anti-Apoptotic Protein Fingerprints in Human Monocyte-Derived Dendritic Cells… Conclusion:  Results of these analyses provide insights into alcohol mechanisms...
4. Combination of Low-Dose Isotretinoin and Pulsed Oral Azithromycin in the Management of Moderate to Severe Acne: A Preliminary Open-Label, Prospective,… (Source: Clinical Drug Investigation)...
5. Request for Applications for Basic, Clinical, and Translational Pediatric Lupus Research Letter of Intent Deadline: April 19, 2010 at 5 p.m....

Leave a comment

Name (required)

E-mail (required)

URI

Your Message